Skip to main content
SpringerLink
Log in

PET/CT and Prostate Cancer

  • Chapter
  • First Online:
Oncological PET/CT with Histological Confirmation

  • 750 Accesses

Abstract

The aim of this chapter is to discuss the role of PET/CT and, more significantly, of 11C- or 18F-choline PET/CT in prostate cancer patients. The chapter will be focused on the role of choline PET/CT in prostate cancer diagnosis as a potential tool to guide biopsy. Molecular imaging has advantages compared to conventional imaging techniques (transrectal ultrasound, contrast-enhanced computed tomography, magnetic resonance imaging) especially for intra-prostatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. ESMO Guidelines Task Force. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of prostate cancer. Ann Oncol. 2005;16 Suppl 1:i34–6.

    Google Scholar 

  2. Heidenreich A, Bellmunt J, Bolla M, Joniau S, van der Kwast TH, Mason MD, et al. Guidelines on prostate cancer. Eur Urol. 2011;59(4):572–83.

    Article  PubMed  Google Scholar 

  3. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin. 2007;57(90):225–49.

    Google Scholar 

  4. Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2011;59(4):572–83.

    Article  PubMed  Google Scholar 

  5. Phelps ME. Inaugural article: positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci U S A. 2000;97:9226–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sandblom G, Sorensen J, Lundin N, Haggman M, Malmstrom PU. Positron patients with prostate-specific antigen relapse after radical prostatectomy. Urology. 2006;67:996–1000.

    Article  PubMed  Google Scholar 

  7. Dehdashti F, Picus J, Michalski JM, Dence CS, Siegel BA, Katzenellenbogen JA, Welch MJ. Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur J Nucl Med Mol Imaging. 2005;32:344–50.

    Article  PubMed  Google Scholar 

  8. Tóth G, Lengyel Z, Balkay L, Salah MA, Trón L, Tóth C. Detection of prostate cancer with 11C-methionine positron emission tomography. J Urol. 2005;173:66–9.

    Article  PubMed  Google Scholar 

  9. Maecke HR, Hofmann M, Haberkorn U. (68)Ga-labeled peptides in tumor imaging. J Nucl Med. 2005;46 Suppl 1:172S–8.

    CAS  PubMed  Google Scholar 

  10. Zeisel SH. Dietary choline: biochemistry, physiology and pharmacology. Annu Rev Nutr. 1981;1:95–121.

    Article  CAS  PubMed  Google Scholar 

  11. Müller SA, Holzapfel K, Seidl C, Treiber U, Krause BJ, Senekowitsch-Schmidtke R. Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment. Eur J Nucl Med Mol Imaging. 2000;36(9):1434–42.

    Article  Google Scholar 

  12. Husarik DB, Miralbell R, Dubs M, John H, Giger OT, Gelet A, Cservenyàk T, Hany TF. Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging. 2008;35(2):253–63.

    Article  PubMed  Google Scholar 

  13. Mueller-Liesse UG, Miller K. Imaging modalities for primary diagnosis and staging of prostate cancer. Urologe A. 2010;49(2):190–8.

    Article  Google Scholar 

  14. Ohori M, Kattan MW, Utsunomiya T, Suyama K, Scardino PT, Wheeler TM. Do impalpable (T1c) cancers visible on ultrasound differ from those not visible? J Urol. 2003;169:964–8.

    Article  PubMed  Google Scholar 

  15. Cornud F, Hamida K, Flam T, Hélénon O, Chrétien Y, Thiounn N, Correas JM, Casanova JM, Moreau JF. Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. AJR Am J Roentgenol. 2000;175:1161–8.

    Article  CAS  PubMed  Google Scholar 

  16. Halpern EJ, Frauscher F, Strup SE, Nazarian LN, O’Kane P, Gomella LG. Prostate: high-frequency Doppler US imaging for cancer detection. Radiology. 2002;225:71–7.

    Article  PubMed  Google Scholar 

  17. Sedelaar JP, Vijverberg PL, De Reijke TM, et al. Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives. Eur Urol. 2001;40:275–84.

    Article  CAS  PubMed  Google Scholar 

  18. Chang JJ, Shinohara K, Bhargava V, et al. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol. 1998;160:2111–4.

    Article  CAS  PubMed  Google Scholar 

  19. Beerlage HP, De Reijke TM, de la Rosette JJ. Considerations regarding prostate biopsies. Eur Urol. 1998;34:303–12.

    Article  CAS  PubMed  Google Scholar 

  20. Akin O, Sala E, Moskowitz CS, Kuroiwa K, Ishill NM, Pucar D, Scardino PT, Hricak H. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology. 2006;239:784–92.

    Article  PubMed  Google Scholar 

  21. Engelbrecht MR, Huisman HJ, Laheij RJ, Jager GJ, van Leenders GJ, Hulsbergen-Van DE Kaa CA, de la Rosette JJ, Bickman JG, Barentsz JO. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology. 2003;229:248–54.

    Article  PubMed  Google Scholar 

  22. Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging—initial experience. Radiology. 2004;233:709–15.

    Article  PubMed  Google Scholar 

  23. Ikonen S, Kivisaari L, Vehmas T, Tervahartiala P, Salo JO, Taari K, Rannikko S. Optimal timing of post-biopsy MR imaging of the prostate. Acta Radiol. 2001;42:70–3.

    Article  CAS  PubMed  Google Scholar 

  24. Qayyum A, Coakley FV, Lu Y, Olpin JD, Wu L, Yeh BM, Carroll PR, Kurhanewicz J. Organ confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol. 2004;183:1079–83.

    Article  PubMed  Google Scholar 

  25. Farsad M, Schwarzenböck S, Krause BJ. PET/CT and choline: diagnosis and staging. Q J Nucl Med Mol Imaging. 2012;56(4):343–53.

    CAS  PubMed  Google Scholar 

  26. De Jong JJ, Prium J, Elsinga PH, Vaalburg W, Mensink HJ. 11C-Choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol. 2003;44(32):32–8; discussion 8–9.

    Article  PubMed  Google Scholar 

  27. Farsad M, Schiavina R, Castellucci P, Nanni C, Corti B, Martorana G, Canini R, Grigioni W, Boschi S, Marengo M, Pettinato C, Salizzoni E, Monetti N, Franchi R, Fanti S. Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. J Nucl Med. 2005;46:1642–9.

    CAS  PubMed  Google Scholar 

  28. Reske SN, Blumstein NM, Neumaier B, Gottfried HW, Finsterbusch F, Kocot D, Moller P, Glatting G, Perner S. Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med. 2006;47:1249–54.

    CAS  PubMed  Google Scholar 

  29. Giovacchini G, Picchio M, Coradeschi E, Scattoni V, Bettinardi C, Cozzarini V, et al. [(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy. Eur J Nucl Med Mol Imaging. 2008;35:1065–73.

    Article  CAS  PubMed  Google Scholar 

  30. Martorana G, Schiavina R, Corti B, Farsad M, Salizzoni E, Brunocilla E, Bertaccini A, Manferrari F, Castellucci P, Fanti S, Canini R, Grigioni WF, D’Errico Grigioni A. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. J Urol. 2006;176:954–60.

    Article  CAS  PubMed  Google Scholar 

  31. Testa C, Schiavina R, Lodi R, Salizzoni E, Corti B, Farsad M, et al. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. Radiology. 2007;244(3):797–806. Epub 2007 Jul 24.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service of Nuclear Medicine, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Azienda Ospedaliero-Universitaria Policlinico S.Orsola-Malpighi, University of Bologna, Bologna, Italy

    Francesco Ceci MD, Paolo Castelluci MD & Tiziano Graziani MD

Authors
  1. Francesco Ceci MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paolo Castelluci MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tiziano Graziani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Ceci MD .

Editor information

Editors and Affiliations

  1. PET/CT Center, Quanta Diagnóstico e Terapia, Curitiba, Paraná, Brazil

    Juliano Cerci

  2. Ospedale S. Orsola Malpighi, Universitary Hospital, Bologna, Italy

    Stefano Fanti

  3. Radiology&Radiological Sciences, Vanderbilt University Medical Cente, Nashville, Tennessee, USA

    Dominique Delbeke

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing

About this chapter

Cite this chapter

Ceci, F., Castelluci, P., Graziani, T. (2016). PET/CT and Prostate Cancer. In: Cerci, J., Fanti, S., Delbeke, D. (eds) Oncological PET/CT with Histological Confirmation. Springer, Cham. https://doi.org/10.1007/978-3-319-27880-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27880-3_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27878-0

  • Online ISBN: 978-3-319-27880-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation